Valuation: Treace Medical Concepts, Inc.

Market Cap 278M 249M 228M 207M 390M 26.37B 399M 2.73B 1.1B 13.92B 1.04B 1.02B 44.11B P/E 2026 *
-5.03x
P/E 2027 * -5.52x
Enterprise Value 324M 289M 266M 241M 454M 30.69B 465M 3.17B 1.28B 16.2B 1.22B 1.19B 51.35B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.65x
Free-Float
74.47%
Yield 2026 *
-
Yield 2027 * -
1 day+0.23%
1 week-5.93%
Current month-3.39%
1 month-2.51%
3 months-8.55%
6 months+130.11%
Current year+74.69%
1 week 4.21
Extreme 4.21
5.25
1 month 3.78
Extreme 3.78
5.25
Current year 1.17
Extreme 1.17
5.25
1 year 1.17
Extreme 1.17
6.55
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
27.97
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Chief Tech/Sci/R&D Officer - 01/03/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Tax

Compliance Officer

-25,457 0.0391%
24/08/26 Buy

Chief Executive Officer

11,000 0.0170%
09/08/26 Tax

Chief Financial Officer

-37,102 0.0572%
Change 5-day change 1-year change 3-year change Capi.($)
+0.23%-5.93%-35.05%-61.23% 278M
-0.69%+6.11%-11.66%+14.15% 189B
-0.41%+5.25%+9.62%+36.27% 121B
+1.22%+3.03%-13.29%+12.43% 118B
+1.17%+4.87%-41.10%+7.93% 94.78B
+0.79%+4.65%-0.13%+74.46% 64.98B
-0.22%+1.61%+11.77%-23.46% 53.98B
+0.06%+19.74%-7.04%+56.54% 52.94B
-1.45%-7.57%-2.88%+55.56% 52.3B
+3.24%+7.01%+1.58%-7.50% 35.25B
Average +1.41%+3.24%-8.82%+16.52% 78.31B
Weighted average by Cap. +1.51%+4.39%-8.12%+23.60%

Financials

2026 *2027 *
Net sales 207M 185M 170M 155M 290M 19.65B 298M 2.03B 818M 10.37B 779M 762M 32.88B 222M 198M 182M 165M 310M 21B 318M 2.17B 874M 11.09B 832M 814M 35.14B
Net income -55.26M -49.37M -45.35M -41.19M -77.35M -5.24B -79.29M -541M -218M -2.76B -207M -203M -8.76B -51.01M -45.57M -41.86M -38.02M -71.4M -4.83B -73.19M -500M -201M -2.55B -191M -187M -8.08B
Net Debt 45.67M 40.8M 37.48M 34.04M 63.92M 4.33B 65.52M 447M 180M 2.28B 171M 168M 7.24B 86.44M 77.22M 70.94M 64.42M 121M 8.19B 124M 847M 341M 4.32B 324M 318M 13.7B
Projected Income Statement - Annual - Treace Medical Concepts, Inc.
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
03/11/26 $4.280 +0.23% 211,636
02/11/26 $4.270 -3.61% 168,692
30/10/26 $4.430 -12.45% 290,596
29/10/26 $5.060 +4.76% 368,086
28/10/26 $4.830 +6.15% 188,467
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Treace Medical Concepts, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.280USD
Average target price
5.500USD
Spread / Average Target
+28.50%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Treace Medical Concepts, Inc.
  1. Stock Market
  2. Stocks
  3. TMCI Stock